Return to Home Mortality > Table > Data Table

Data Table for Rate/Trend Comparison by State/County

Death Rate/Trend Comparison by State/County, 2016-2020

District of Columbia versus United States

All Races, Both Sexes

Sorted by priority index
Cancer Site and Sex
sort alphabetically by cancer site ascending 		Priority Index1
1=highest
9=lowest
sort by priority index ascending 		Recent Trend2
 County Death
Rate
Compared
to
US Rate
 Average Annual Count
sort by count descending 		Age-Adjusted Death Rate

deaths per 100,000
(95% Confidence Interval)
sort by rate descending 		Rate
Ratio3
County
to
US
sort by rate descending 		Recent 5-Year Trend2 in Death Rates
(95% Confidence Interval)
sort by trend descending
Leukemia (Male) 9 falling falling trend lower 17 6.2 (4.9, 7.6) 0.8 -2.0 (-2.8, -1.1)
Lung & Bronchus (Female) 9 falling falling trend lower 89 22.4 (20.3, 24.7) 0.8 -7.6 (-11.6, -3.3)
Lung & Bronchus (Male) 9 falling falling trend lower 95 33.2 (30.2, 36.4) 0.8 -6.2 (-7.5, -4.9)
Bladder (Male) 8 falling falling trend similar 17 6.2 (4.9, 7.7) 0.9 -1.4 (-2.4, -0.3)
Colon & Rectum (Female) 8 falling falling trend similar 49 12.4 (10.9, 14.1) 1.1 -2.7 (-3.2, -2.2)
Colon & Rectum (Male) 8 falling falling trend similar 46 15.9 (13.9, 18.2) 1.0 -3.1 (-3.7, -2.5)
Ovary (Female) 8 falling falling trend similar 23 6.0 (5.0, 7.3) 1.0 -1.0 (-1.8, -0.2)
Stomach (Male) 8 falling falling trend similar 13 4.4 (3.3, 5.6) 1.2 -3.8 (-4.7, -2.9)
Pancreas (Male) 6 stable stable trend similar 41 14.0 (12.1, 16.1) 1.1 -0.3 (-0.9, 0.2)
Breast (Female) 5 falling falling trend higher 92 23.5 (21.3, 25.8) 1.2 -2.1 (-2.5, -1.7)
Prostate (Male) 5 falling falling trend higher 72 26.9 (24.2, 29.9) 1.4 -3.3 (-3.8, -2.7)
Pancreas (Female) 4 stable stable trend higher 48 12.2 (10.7, 13.8) 1.3 -0.1 (-0.7, 0.4)
Liver & Bile Duct (Female) 1 rising rising trend higher 21 5.2 (4.3, 6.4) 1.3 1.3 (0.1, 2.4)
Liver & Bile Duct (Male) 1 rising rising trend higher 45 14.2 (12.3, 16.2) 1.5 1.6 (0.9, 2.3)
Uterus (Corpus & Uterus, NOS) (Female) 1 rising rising trend higher 41 10.2 (8.8, 11.7) 2.0 1.6 (0.6, 2.6)
Bladder (Female)
**
 		** similar 10 2.4 (1.7, 3.2) 1.2
**
Brain & ONS (Female)
**
 		** lower 10 2.7 (2.0, 3.6) 0.8
**
Brain & ONS (Male)
**
 		** lower 11 3.2 (2.4, 4.2) 0.6
**
Cervix (Female)
**
 		** similar 9 2.4 (1.8, 3.3) 1.1
**
Esophagus (Female)
**
 		** similar 7 1.7 (1.2, 2.4) 1.2
**
Esophagus (Male)
**
 		** lower 14 4.9 (3.8, 6.3) 0.7
**
Kidney & Renal Pelvis (Female)
**
 		** similar 6 1.6 (1.1, 2.4) 0.8
**
Kidney & Renal Pelvis (Male)
**
 		** lower 11 3.4 (2.5, 4.5) 0.7
**
Leukemia (Female)
**
 		** lower 14 3.4 (2.6, 4.3) 0.8
**
Melanoma of the Skin (Male)
**
 		** lower 4 1.5 (0.9, 2.4) 0.5
**
Non-Hodgkin Lymphoma (Female)
**
 		** similar 13 3.3 (2.6, 4.3) 0.9
**
Non-Hodgkin Lymphoma (Male)
**
 		** lower 15 5.3 (4.1, 6.6) 0.8
**
Oral Cavity & Pharynx (Female)
**
 		** similar 5 1.3 (0.9, 2.0) 1.0
**
Oral Cavity & Pharynx (Male)
**
 		** similar 12 4.0 (3.0, 5.2) 1.0
**
Stomach (Female)
**
 		** similar 11 2.8 (2.1, 3.7) 1.3
**
Childhood (Ages <15, All Sites) (Female)
**
 		**
*
3 or fewer
*
*
**
Childhood (Ages <15, All Sites) (Male)
**
 		**
*
3 or fewer
*
*
**
Childhood (Ages <20, All Sites) (Female)
**
 		**
*
3 or fewer
*
*
**
Childhood (Ages <20, All Sites) (Male)
**
 		**
*
3 or fewer
*
*
**
Melanoma of the Skin (Female)
**
 		**
*
3 or fewer
*
*
**
Thyroid (Female)
**
 		**
*
3 or fewer
*
*
**
Thyroid (Male)
**
 		**
*
3 or fewer
*
*
**
Notes:
Created by statecancerprofiles.cancer.gov on 05/05/2024 12:51 pm.

Trend2
     Rising    when 95% confidence interval of average annual percent change is above 0.
     Stable    when 95% confidence interval of average annual percent change includes 0.
     Falling    when 95% confidence interval of average annual percent change is below 0.
Rate Comparison
     Above    when 95% confident the rate is above and Rate Ratio3 > 1.10
     Similar    when unable to conclude above or below with confidence.
     Below    when 95% confident the rate is below and Rate Ratio3 < 0.90

* Data has been suppressed to ensure confidentiality and stability of rate and trend estimates.
** Data are too sparse to provide stable estimates of annual rates needed to calculate trend.
1 Priority indices were created by ordering from rates that are rising and above the comparison rate to rates that are falling and below the comparison rate.
2 Recent trend in death rates is usually an Average Annual Percent Change (AAPC) based on the APCs calculated by Joinpoint Version 4.8.0.0. Due to data availability issues, the time period and/or calculation method used in the calculation of the trends may differ for selected geographic areas.
3 Rate ratio is the county rate divided by the US rate. Previous versions of this table used one-year rates for states and five-year rates for counties. As of June 2018, only five-year rates are used.
Source: Death data provided by the National Vital Statistics System public use data file. Death rates calculated by the National Cancer Institute using SEER*Stat. Death rates are age-adjusted to the 2000 US standard population (19 age groups: <1, 1-4, 5-9, ... , 80-84, 85+). The Healthy People 2020 goals are based on rates adjusted using different methods but the differences should be minimal. Population counts for denominators are based on Census populations as modified by NCI. The US Population Data File is used with mortality data.
Note: When the population size for a denominator is small, the rates may be unstable. A rate is unstable when a small change in the numerator (e.g., only one or two additional cases) has a dramatic effect on the calculated rate. Suppression is used to avoid misinterpretation when rates are unstable.

State Cancer Registries may provide more current or more local data. Data presented on the State Cancer Profiles Web Site may differ from statistics reported by the State Cancer Registries (for more information).

Data for the following has been suppressed to ensure confidentiality and stability of rate and trend estimates:
Childhood (Ages <15, All Sites) (Female), Childhood (Ages <15, All Sites) (Male), Childhood (Ages <20, All Sites) (Female), Childhood (Ages <20, All Sites) (Male), Melanoma of the Skin (Female), Thyroid (Female), Thyroid (Male)

Trend for the following could not be reliably determined due to small number of deaths per year:
Bladder (Female), Brain & ONS (Female), Brain & ONS (Male), Cervix (Female), Esophagus (Female), Esophagus (Male), Kidney & Renal Pelvis (Female), Kidney & Renal Pelvis (Male), Leukemia (Female), Melanoma of the Skin (Male), Non-Hodgkin Lymphoma (Female), Non-Hodgkin Lymphoma (Male), Oral Cavity & Pharynx (Female), Oral Cavity & Pharynx (Male), Stomach (Female)


Interpret Rankings provides insight into interpreting cancer statistics. When the population size for a denominator is small, the rates may be unstable. A rate is unstable when a small change in the numerator (e.g., only one or two additional cases) has a dramatic effect on the calculated rate.

Data for United States does not include Puerto Rico.

Return to Top